Medicare Enrolled

Dr. Mani Khoshnejad, M.D.

Family Medicine · Baytown, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2223 ROLLINGBROOK DR., Baytown, TX 77521
2814203565
In practice since 2007 (18 years)
NPI: 1275732976 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khoshnejad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khoshnejad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khoshnejad

Dr. Mani Khoshnejad is a family medicine in Baytown, TX, with 18 years in practice. Based on federal Medicare data, Dr. Khoshnejad performed 3,856 Medicare services across 1,497 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khoshnejad received a total of $14,039 from 80 pharmaceutical and/or device companies across 884 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khoshnejad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 5% volume in TX$ $14,039 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,856
Medicare services
Top 5% in TX for family medicine
1,497
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~214 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)637$90$170
Injection, ketorolac tromethamine, per 15 mg560$0$10
Dexamethasone injection (steroid)408$0$10
Ceftriaxone antibiotic injection352$0$10
Detection test by immunoassay with direct visual observation for influenza virus248$16$35
Injection, methylprednisolone acetate, 40 mg239$5$31
Drug injection, under skin or into muscle238$10$45
Steroid injection (triamcinolone)168$1$10
Electrocardiogram (EKG), 12-lead142$10$60
Test to measure expiratory airflow and volume129$17$60
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus126$34$75
Annual wellness visit, follow-up121$134$195
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)120$16$35
Office visit, established patient (20-29 min)94$58$120
Injection, methylprednisolone acetate, 20 mg63$5$10
Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage55$22$50
Flu vaccine administration54$31$45
Injection into tendon or ligament34$46$93
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional27$19$40
Transitional care management services for problem of high complexity17$193$256
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes13$27$35
Advance care planning consultation, first 30 min11$81$100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,039
Total received (2018-2024)
Avg $2,006/year across 7 years
Top 2% in TX for family medicine
80
Companies
884
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,039 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,842
2023
$2,629
2022
$2,127
2021
$2,001
2020
$783
2019
$2,560
2018
$2,098

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$2,159
AstraZeneca Pharmaceuticals LP
$1,870
GlaxoSmithKline, LLC.
$858
Lilly USA, LLC
$726
ABBVIE INC.
$677
Antares Pharma, Inc.
$574
SANOFI-AVENTIS U.S. LLC
$401
AbbVie Inc.
$395
Amgen Inc.
$374
Takeda Pharmaceuticals U.S.A., Inc.
$352
Janssen Pharmaceuticals, Inc
$327
Merck Sharp & Dohme Corporation
$283
Astellas Pharma US Inc
$271
Tolmar, Inc.
$260
Corium, LLC
$260
Harmony Biosciences LLC
$237
Amarin Pharma Inc.
$233
Axsome Therapeutics, Inc.
$227
Bayer Healthcare Pharmaceuticals Inc.
$210
PFIZER INC.
$204
JAZZ PHARMACEUTICALS INC.
$192
Supernus Pharmaceuticals, Inc.
$191
Endo Pharmaceuticals Inc.
$143
Novartis Pharmaceuticals Corporation
$137
Boehringer Ingelheim Pharmaceuticals, Inc.
$126
MannKind Corporation
$120
Almatica Pharma LLC
$107
Merck Sharp & Dohme LLC
$99
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$90
Tris Pharma Inc
$85
Genentech USA, Inc.
$84
Sumitomo Pharma America, Inc.
$79
IBSA Pharma Inc.
$75
Otsuka America Pharmaceutical, Inc.
$71
Currax Pharmaceuticals LLC
$70
Biohaven Pharmaceuticals, Inc.
$70
Shire North American Group Inc
$70
Corcept Therapeutics
$68
Eisai Inc.
$64
Adlon Therapeutics L.P.
$62
Paratek Pharmaceuticals, Inc.
$60
Mannkind Corporation
$60
Acerus Pharmaceuticals Corporation
$55
Horizon Pharma plc
$54
Allergan, Inc.
$54
Allergan Inc.
$45
Ironwood Pharmaceuticals, Inc
$45
Biohaven Pharmaceutical Holding Company Ltd.
$45
HARMONY BIOSCIENCES LLC
$43
ARBOR PHARMACEUTICALS, INC.
$43
Jazz Pharmaceuticals Inc.
$40
Phathom Pharmaceuticals, Inc.
$39
Sunovion Pharmaceuticals Inc.
$37
Ironshore Pharmaceuticals Inc.
$37
Exact Sciences Corporation
$35
Verity Pharmaceuticals Inc.
$32
Horizon Therapeutics plc
$31
Kowa Pharmaceuticals America, Inc.
$29
Medtronic USA, Inc.
$24
GENZYME CORPORATION
$21
Intuity Medical Inc
$20
KVK-Tech, Inc.
$20
Abbott Laboratories
$19
Azurity Pharmaceuticals, Inc.
$19
Esperion Therapeutics, Inc.
$17
Dexcom, Inc.
$17
Phadia US Inc.
$17
Melinta Therapeutics, Inc.
$15
Nevro Corp.
$15
Regeneron Healthcare Solutions, Inc.
$15
SCYNEXIS, Inc.
$15
ASSERTIO THERAPEUTICS, Inc.
$15
Neos Therapeutics, LP
$15
EISAI INC.
$14
Nabriva Therapeutics, plc
$14
IDORSIA PHARMACEUTICALS US INC
$14
DERMIRA, INC.
$14
Shield Therapeutics Inc
$14
Acclarent, Inc
$14
Clarus Therapeutics Inc.
$6
Top 3 companies account for 34.8% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADHANSIA XR · AFREZZA · AIRSUPRA · ANORO · AREXVY · AZSTARYS · Adzenys XR-ODT · Aimovig · Amitiza · Azstarys · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Baxdela · CHANTIX · CONTRAVE · CREON · Cologuard Collection Kit · DUEXIS · DUPIXENT · DUZALLO · Dayvigo · Dexcom G6 Transmitter · Dyanavel XR · ELIGARD · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbyclor · FARXIGA · FREESTYLE LIBRE 3 · GARDASIL 9 · GEMTESA · GRALISE · Gralise · HUMALOG · Horizant · INTELLIS · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · JORNAY PM · Kerendia · Korlym · LATUDA · LEQVIO · LICART · LINZESS · LOREEV XR · LYRICA · Linzess · Livalo · MOTEGRITY · MOUNJARO · MYDAYIS · MYRBETRIQ · Motegrity · Myrbetriq · NAPRELAN · NASCOBAL · NEXLETOL · NOCDURNA · NURTEC ODT · NUZYRA · Natesto · ONZETRA XSAIL · OTREXUP · Otezla · Otrexup · Ozempic · PENNSAID · PNEUMOVAX 23 · PRALUENT ALIROCUMAB INJECTION · PREMARIN · Pogo Automatic Blood Glucose Monitoring System · Prolia · QBREXZA · QELBREE · QULIPTA · QUVIVIQ · RAYOS · RELIEVA SPINPLUS Balloon Sinuplasty System · REXULTI · ROTATEQ · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · Senza · Sivextro · Sunosi · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · TZIELD · Tirosint · Tlando · Tresiba · Trintellix · UBRELVY · Utibron · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · WAKIX · Wakix · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.

Equivalent to $364 per 100 Medicare services performed
Looking for a family medicine in Baytown?
Compare family medicines in the Baytown area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
621
Per 100K population
13.1
County median income
$73,104
Nearest hospital
HOUSTON METHODIST BAYTOWN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Khoshnejad is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (low-engagement, top 2%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Khoshnejad experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khoshnejad performed 637 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khoshnejad receive payments from pharmaceutical companies?
Yes. Dr. Khoshnejad received a total of $14,039 from 80 companies across 884 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khoshnejad's costs compare to other family medicines in Baytown?
Dr. Khoshnejad's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khoshnejad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →